Spain asks EMA to allow 'dose-sparing' for monkeypox vaccine

The country has the world's second-largest number of monkeypox infections outside the areas where it is endemic.

More than 5,000 cases have been confirmed since May, including two deaths, placing it behind only the United States, which registered 9,492 cases as of Wednesday.

Spain's Health Ministry did not specify how many doses it hoped to obtain from one vial, but Madrid's regional health authority had earlier requested the same scheme as in the United States.

Supplies of Jynneos, the only vaccine approved for the prevention of monkeypox, produced by Denmark-headquartered drugmaker Bavarian Nordic, are scarce. Spain has only received around 12,000 vaccines via a joint European Union-coordinated purchase.

The dose-sparing approach has been tried with other vaccines, but evidence is limited on whether it could work for monkeypox.

More than 30,000 cases and 12 deaths have been reported worldwide after the World Health Organization declared monkeypox a global health emergency on July 24.

The Balearic Ministry for Health has confirmed 155 cases of monkeypox in the Balearic Islands as of Thursday 11 August.

By islands, 86 correspond to Mallorca, 60 to Ibiza, 2 to Menorca and 7 to Formentera.

Since this health alert was declared, 213 suspected cases have been investigated in the Balearic Islands, 46 of which have been ruled out and 12 are still under investigation.